Operational & Financial Highlights 2016
Summary Financial Results
Financial Year Ended 31 December 2016
Revenue €’000
Star had a
standout year
2016
1,296,320
Turnover doubled and
Contract Sales Outsourcing
(CSO) headcount increased
to almost 300.
2015
1,118,638
EBITDA* €’000
2016
24,693
10,000 home patients
20% growth in
PharmaSource’s Market
Access and Managed
Access solutions
As well as supporting manufacturers to
get products onto the market, Uniphar
is now off ering product fostering through
Dialachemist Limited (trading as Springmed
Solutions) and providing manufacturers
with a complete product life cycle service.
110,000 sq ft
Phase 1 of the Greenogue facility
development was completed,
creating 110,000 square feet
of additional warehousing in a
state of the art, fully automated
24-hour warehouse.
Within the past year, the Uniphar Group
have helped close to 10,000 patients
in their homes throughout Ireland.
Marketplace went live in 2016
This currently enables Life and Allcare members
to operate an ethical product “One Stop Shop”
by off ering the purchasing pharmacist the
best deal in the market.
2015
20,987
Operating profi t** €’000
2016
8,953
2015
8,370
Profi t before tax €’000
excluding exceptional items
2016
15,930
2015
12,792
Net debt €’000
70% of customers
converted to web 2016
Our customers have taken full advantage of
Uniphar’s excellent web portal with 70% of
non DOE/PIMS business carried out online
after just two years. Adjusted EPS cent
46,089
2015
65,926
excluding exceptional items
2016
12.5
2015
11.4
* EBITDA: Earnings before interest, tax, depreciation, amortisation and
exceptional items.
** Operating profi t is stated before fi nance costs and income tax and after
exceptional items.
2 | Annual Report 2016
Annual Report 2016 | 3